Polycarbonate Urethane Mesh: A New Material for Pelvic Reconstruction

Area of Science:

• Biomaterials Science
• Immunology
• Tissue Engineering

Background:

• Polycarbonate urethane (PCU) is a novel biomaterial with tunable mechanical properties.
• Its potential for vaginal tissue repair, specifically for pelvic organ prolapse, requires evaluation of host tissue response.
• Comparing PCU to existing materials like polypropylene (PP) mesh is crucial for clinical translation.

Purpose of the Study:

• To investigate and compare the host immune and extracellular matrix responses to PCU versus PP vaginal mesh implantation.
• To assess the biocompatibility of PCU in a vaginal tissue context.

Main Methods:

• A rat model involving hysterectomy and ovariectomy was used, with groups receiving PCU mesh, PP mesh, or sham surgery.
• Vaginal tissues were analyzed after 90 days for histomorphology, macrophage subsets, cytokine profiles, matrix metalloproteinases (MMPs), and collagen composition.
• Quantitative analyses included histology, immunolabeling, Luminex assays, ELISA, and picrosirius red staining.

Main Results:

• Histomorphologic scores were similar between PCU and PP mesh groups, with both showing a higher response than controls.
• No significant differences were observed in macrophage subsets, pro-inflammatory/anti-inflammatory cytokines, MMP-2/-9 levels, or collagen ratios between PCU and PP groups.
• The host inflammatory response surrounding PCU mesh was minimal.

Conclusions:

• Polycarbonate urethane (PCU) elicits a minimal host inflammatory response in a rat vaginal model, comparable to lightweight polypropylene (PP).
• PCU's biocompatibility suggests it is a viable candidate for pelvic organ prolapse repair.
• Further investigation in larger animal models is warranted to explore PCU mesh for prolapse treatment.